
|Videos|October 10, 2016
An Overview of the AM0010 Study in Kidney Cancer, Other Cancers
Author(s)Jeffrey Infante, MD
Jeffrey Infante, MD, Director of Drug Development at Sarah Cannon, discusses findings of the AM0010 study.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Oncology Update January 2026: New Horizons in Precision Medicine
2
Building Better ADCs for GI Cancers: Targets, Timing, and Toxicities
3
The Targeted Pulse: New Standards in Myeloma, Melanoma, and More
4
Gemogenovatucel-T Triples Overall Survival in High-Risk HRP Ovarian Cancer
5



















